# Rui Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rui-wang-5/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,055 |
| Field | Cancer-related molecular mechanisms research |
| h-index | 69 |
| i10-index | 323 |
| Last Known Institution | University of Nottingham |
| OpenAlex ID | https://openalex.org/A5100431366 |
| ORCID iD | https://orcid.org/0000-0003-1723-4746 |
| Works | 878 |

## Researcher papers

- [Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial](https://scholariq.org/papers/camrelizumab-plus-carboplatin-and-paclitaxel-as-first-line-treatment-for/)
- [The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity](https://scholariq.org/papers/the-superior-efficacy-of-anti-pd-1-pd-l1-immunotherapy-in-kras-mutant-non-small/)

## Researcher topics

- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Bacteriophages and microbial interactions](https://scholariq.org/topics/bacteriophages-and-microbial-interactions/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Researcher university

- [University of Nottingham](https://scholariq.org/institutions/university-of-nottingham/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.